RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells

Journal of Investigative Dermatology

Volumn 131, Issue 4, 2011, Pages 944-955

  Kupas, Verena ^a   Weishaupt, Carsten ^a   Siepmann, Dorothee ^a   Kaserer, Maria Laura ^a   Eickelmann, Mareike ^a   Metze, Dieter ^a   Luger, Thomas A ^a   Beissert, Stefan ^a   Loser, Karin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CD133 ANTIGEN; KI 67 ANTIGEN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ARTICLE; CANCER STAGING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR EMBOLISM; TUMOR GROWTH; UPREGULATION;

EID: 79952764688     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.377     Document Type: Article

References (35)

1. Al Dhaybi R, Sartelet H, Powell J et al. (2010) Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Modern Pathol 23:367-80
2. Al-Hajj M, Wicha MS, Benito-Hernandez A et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-8 (Pubitemid 36418143)
3. Armstrong AP, Miller RE, Jones JC et al. (2008) RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate 68:92-104
4. Balint K, Xiao M, Pinnix CC et al. (2005) Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 115:3166-76 (Pubitemid 41567581)
5. Ben-Baruch A (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345-56 (Pubitemid 351748979)
6. Bhatia P, Sanders MM, Hansen MF (2005) Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma. Clin Cancer Res 11:162-5 (Pubitemid 40075791)
7. Blair JM, Zheng Y, Dunstan CR (2007) RANK ligand. Int J Biochem Cell Biol 39:1077-81 (Pubitemid 46819130)
8. Chen G, Sircar K, Aprikian A et al. (2006) Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107:289-98 (Pubitemid 44036558)
9. Essner R, Belhocine T, Scott AM et al. (2006) Novel imaging techniques in melanoma. Surg Oncol Clin N Am 15:253-83
10. Fusi A, Reichelt U, Busse A et al. (2010) Expression of the stem cell markers nestin and CD133 on circulating melanoma cells. J Invest Dermatol 131:487-94
11. Herlyn M (2009) Driving in the melanoma landscape. Exp Dermatol 18:506-8
12. Houghton A, Coit D, Bloomer W et al. (1998) NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology 12:153-77
13. Jones DH, Nakashima T, Sanchez OH et al. (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692-6
14. Klein WM, Wu BP, Zhao S et al. (2007) Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20:102-7 (Pubitemid 44967955)
15. Kochhar R, Ali H, Mak S et al. (2009) Metastatic cutaneous malignant melanoma: spectrum of imaging findings and the role of multimodality imaging. J Med Imaging Radiat Oncol 53:467-79
16. Kuphal S, Bosserhoff A (2009) Recent progress in understanding the pathology of malignant melanoma. J Pathol 219:400-9
17. Lacey DL, Timms E, Tan HL et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-76 (Pubitemid 28180851)
18. Maeurer MJ, Gollin SM, Martin D et al. (1996) Tumor escape from immune recognition. J Clin Invest 98:1633-41
19. Mikami S, Katsube K, Oya M et al. (2009) Increased RANKL expression is related to tumor migration and metastasis of renal cell carcinomas. J Pathol 218:530-9
20. Mohr P, Eggermont AM, Hauschild A et al. (2009) Staging of cutaneous melanoma. Ann Oncol 20(Suppl 6):vi14-21
21. Moore MA (2001) The role of chemoattraction in cancer metastases. Bioessays 23:674-6 (Pubitemid 32792510)
22. Mori K, Ando K, Heymann K et al. (2009) Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells? Histol Histopathol 24:235-42
23. Penno H, Nilsson O, Brändström H et al. (2009) Expression of RANK-ligand in prostate cancer cell lines. Scand J Clin Lab Invest 69:151-5
24. Quintana E, Shackleton M, Sabel MS et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456:593-8
25. Rappa G, Fodstad O, Lorico A (2008) The stem cell-associated antigen CD133 (prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26:3008-17
26. Refaeli Y, Bhoumik A, Roop DR et al. (2009) Melanoma-initiating cells: a compass needed. EMBO Rep 10:965-72
27. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-5 (Pubitemid 46067311)
28. Sasaki A, Ishikawa K, Haraguchi N et al. (2007) Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Ann Surg Oncol 14:1191-9
29. Schatton T, Frank MH (2007) Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 21:39-55
30. Schatton T, Murphy GF, Frank NY et al. (2008) Identification of cells initiating human melanomas. Nature 451:345-9
31. Smalley KSM, Herlyn M (2009) Integrating tumor-initiating cells into the paradigm for melanoma targeted therapy. Int J Cancer 124:1245-50
32. Walsh MC, Choi Y (2003) Biology of the TRANCE axis. Cytokine Growth Factor Rev 14:251-63 (Pubitemid 36693145)
33. Weeraratna AT, Jiang Y, Hostetter G et al. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1:279-88 (Pubitemid 41039152)
34. Weinberg AS, Ogle CA, Shim EK (2007) Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 33:885-99 (Pubitemid 47106729)
35. Zabierowski SE, Herlyn M (2008) Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 26:2890-4